Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: arnie h who wrote (502)	3/30/1998 6:15:00 PM
From: yosi s	Respond to of 1491

PARS Is going to do well I expect the next move to be a slight one up. And it will be with the launching of alrex and lotemax on the market. Again at that time we will see the package insert and the promotion by BOL. At present sellers are taking some of their profit. At this point I do not think PARS is overvalued at 3.5$ so I am not a seller. I am fully invested and will consider margining Im regard to CEPH It is on my screen, provigil is grossly discounted, but it does not look like their myotropin is getting anywhere. it became "political" (thanks for the mention.) best regards yosi